Dyne Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell DYN and other ETFs, options, and stocks.About DYN
Dyne Therapeutics, Inc. engages in developing innovative life-transforming therapies for genetically driven muscle diseases. It develops a broad portfolio of therapeutics for muscle diseases, including lead programs in myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral muscular dystroph.
CEOJohn G. Cox
CEOJohn G. Cox
Employees191
Employees191
HeadquartersWaltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded2017
Founded2017
Employees191
Employees191
DYN Key Statistics
Market cap2.78B
Market cap2.78B
Price-Earnings ratio-4.66
Price-Earnings ratio-4.66
Dividend yield—
Dividend yield—
Average volume2.12M
Average volume2.12M
High today$17.26
High today$17.26
Low today$16.86
Low today$16.86
Open price$17.04
Open price$17.04
Volume920.48K
Volume920.48K
52 Week high$25.00
52 Week high$25.00
52 Week low$6.36
52 Week low$6.36
Stock Snapshot
Dyne Therapeutics(DYN) stock is priced at $17.18, giving the company a market capitalization of 2.78B. It carries a P/E multiple of -4.66.
On 2026-01-14, Dyne Therapeutics(DYN) stock traded between a low of $16.86 and a high of $17.26. Shares are currently priced at $17.18, which is +1.9% above the low and -0.5% below the high.
Dyne Therapeutics(DYN) shares are trading with a volume of 920.48K, against a daily average of 2.12M.
During the past year, Dyne Therapeutics(DYN) stock moved between $6.36 at its lowest and $25.00 at its peak.
During the past year, Dyne Therapeutics(DYN) stock moved between $6.36 at its lowest and $25.00 at its peak.
Analyst ratings
88%
of 16 ratingsBuy
87.5%
Hold
12.5%
Sell
0%
People also own
Based on the portfolios of people who own DYN. This list is generated using Robinhood data, and it’s not a recommendation.